OGI Organigram Global Inc.

0.6296USD-6.95%Mkt Cap: 88.85M USDP/E: 1.46

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vap…

Institutional holders20 on file

Key Statistics

Company
Market Cap88.85M USD
Enterprise Value186.45M USD
Revenue (TTM)216.13M USD
Gross Profit63.06M USD
Net Income (TTM)-17.31M USD
Revenue/Share1.59 USD
Last Price0.6296 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees1.1K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)1.46
P/E (Forward)29.98
PEG—
EV/EBITDA11.35
EV/Revenue0.86
P/S0.29
P/B0.26
EPS (TTM)0.30 USD
EPS (Forward)0.01 USD
52W Range
0.62810% of range2.240
52W High2.240 USD
52W Low0.6281 USD
Profitability
Gross Margin34.81%
Oper. Margin-2.16%
EBITDA Margin5.31%
Profit Margin-9.55%
ROE-7.09%
ROA-4.40%
ROIC-2.99%
ROCE-3.51%
Growth
Revenue Growth49.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.31M USD
CapEx (TTM)11.92M USD
FCF Margin-0.40%
FCF Yield-0.98%
Net Debt13.97M USD
Net Debt/EBITDA1.22
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio2.61
Quick Ratio0.94
Book Value/Sh1.71 USD
Cash/Share0.06 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 7, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.141.11M
Float97.33M
Insiders31.03%
Institutions6.36%
Short Interest
Short Ratio14.7d
Short % Out.3.68%
Shares Short5.31M
Short (prev mo.)4.49M
Technical
SMA 500.9738 (-35.3%)
SMA 2001.161 (-45.8%)
Beta1.98
S&P 52W Chg12.08%
Avg Vol (30d)588.41K
Avg Vol (10d)1.04M
Technical Indicators
RSI (14)17.0
MACD-0.0747
MACD Signal-0.0500
MACD Hist.-0.0247
BB Upper1.071 USD
BB Middle0.8646 USD
BB Lower0.6581 USD
BB Width47.76%
ATR (14)0.0500 USD
Vol Ratio (20d)2.00x

About Organigram Global (NASDAQ: OGI)

›

Organigram Global (NASDAQ: OGI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 1,139 employees.

The shares were at 0.6296 USD on 19 November 2026, down 61.8% over 52 weeks. Its 52-week range is 0.6281 USD to 2.240 USD, and it trades at the bottom of that range.

At a market capitalisation of 88.85M USD, it trades at 1.5 times trailing earnings and 30.0 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 94% for OGI.

Organigram Global reports return on equity of -7.1%, an operating margin of -2.2% and revenue up 49.4% year over year.

Its debt exceeds its cash by 19.98M CAD, a debt-to-equity ratio of 0.03. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 15 December 2026.